Polus Biopharm Rehabilitation Procedure Initiation 'On Hold'
[Asia Economy Reporter Lim Onyu] Polus Biopharm announced on the 13th that the Seoul Bankruptcy Court has postponed its decision on whether to commence rehabilitation proceedings.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The court explained, "To support negotiations on restructuring between creditors and the debtor, the decision on whether to commence rehabilitation proceedings in this case will be postponed until the 31st."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
